Zoledronic Acid Injection is a potent bisphosphonate medication designed for intravenous infusion to treat and prevent bone weakening conditions such as osteoporosis caused by menopause or prolonged steroid use. This injectable solution effectively reduces the risk of bone fractures by inhibiting bone resorption. Additionally, it is employed to manage hypercalcemia (high calcium levels) in patients with cancer, helping restore normal calcium balance and improve clinical outcomes. Zoledronic Acid Injection is suitable for healthcare providers in hospitals and clinics focusing on bone-related disorders and cancer-related metabolic issues.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Zoledronic Acid |
| Formulation | Injection for Intravenous Infusion |
| Indications | Osteoporosis prevention and treatment; Hypercalcemia of malignancy |
| Mechanism of Action | Inhibits bone resorption by osteoclasts |
| Administration Route | Intravenous (IV) infusion |
| Dosage Form | Liquid Injection |
| Packaging | Vial containing Zoledronic Acid solution |
| Therapeutic Category | Bisphosphonate |
| Clinical Use | Prevention of bone fractures; management of cancer-related elevated calcium levels |
| Attributes | Description |
|---|---|
| Concentration | Typically 4 mg per 5 ml vial |
| Storage Conditions | Store at 2°C to 8°C, protect from light |
| Shelf Life | 2 years from manufacturing date |
| Administration Frequency | Once yearly for osteoporosis; As prescribed for hypercalcemia |
| Compatibility | Dilutable with 0.9% Sodium Chloride or 5% Dextrose Injection for infusion |
| Precautions | Monitor kidney function before and after infusion |
| Side Effects | Possible fever, flu-like symptoms, hypocalcemia, renal impairment |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Zoledronic Acid Injection is effective in treating osteoporosis caused by menopause or steroid use and managing high calcium levels in cancer patients.
This medication is given via intravenous infusion, typically once yearly for osteoporosis prevention and as prescribed for hypercalcemia treatment.
Yes, it should be stored at refrigerated temperatures between 2°C to 8°C and protected from light to maintain stability.
Kidney function must be closely monitored before and after infusion as the drug may cause renal impairment.
Yes, it can be diluted with 0.9% Sodium Chloride or 5% Dextrose solutions prior to administration.
Country Of Origin: India
Zoledronic acid Infusion is used to treat or prevent weakening of the bones (osteoporosis) caused by menopause or use of steroids. Using this medicine can reduce your risk of breaking bones. It is also used to treat high levels of calcium in people who have cancer.
